Flat growth masks strong underlying momentum, cost inflation clouds near-term outlook
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Affordable Housing met guidance (30% AUM YoY vs 25%+ target). Private markets on track. But overall revenue +0.1% vs implied 15-20% guidance expectation—significant miss.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
JM Financial is executing well on long-term initiatives (20% revenue growth target, AUM expansion) and hit Affordable Housing guidance (+30% AUM YoY), but Q2 growth of +0.1% reveals execution gaps: deal compression ₹40-50 Cr, regulatory broking headwinds, and recruitment-driven cost inflation. Near-term revenue stagnation conflicts with confident guidance, making the risk/reward neutral at current valuation.
₹1032.2 Cr
Revenue · +0.1% YoY₹227.7 Cr
Reported PAT · −13.1% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Q2 results supported by strong capital markets performance
OVERSTATEDCapital markets revenue ₹286 Cr, up 2.5x QoQ but deal sizes compressed ₹40-50 Cr YoY. Overall revenue +0.1% YoY.
Private markets business seeing 20% YoY growth
METStandard loan book grew 22% YoY to ₹4,748 Cr, AUM ₹4,000 Cr up 30%. Claims aligned with actuals.
Affordable housing targeting 25%+ AUM growth
METAchieved 30% YoY AUM growth and 48% disbursement growth. Exceeded prior Q1 target of 28%.
Wealth AUM & loans showing very good traction
METWealth loan book ₹2,600 Cr (30% YoY), recurring AUM ₹37,000 Cr (16% YoY). Growth solid but revenue impact diluted by broking headwinds.
Earnings quality
What changed since the last call
Deal velocity improving post-June slump
UpgradeJune-July weak; Sept strong. Management now says momentum 'decent' in October. But September was cherry-picked; overall Q2 revenue still +0.1% YoY.
Revenue guidance reiterated at 20% blended, not raised
NeutralManagement confirmed 15-20% growth for capital markets, 20% loan book growth for private markets, 20-25% AUM for wealth. No upward revision despite earlier Q1 optimism.
ARC business now 'lumpy' per management framing
DowngradeExpected ₹250-300 Cr recovery by March, vs prior guidance of steady earnings lift. Timing uncertainty introduced.
Wealth productivity efforts yield near-term cost, not margin gain
DowngradeTeam rationalization underway; profitability recovery delayed to FY28. Near-term NPM pressure continues.
The Q&A
Analysts pressed hard on the revenue growth paradox—strong AUM/loan book growth across segments but flat consolidated revenue. Management deflected with FVD swings, ARC lumpiness, and deal compression. Dodged on buyback specifics; acknowledged capital constraints. Held firm on 20% long-term guidance despite near-term weakness.
Capital markets deal pipeline — Digant Haria, GreenEdge Wealth
PartialPipeline ₹130K Cr filed with regulator. June was weak, Sept strong. Primary market interest and FPI participation returned. October 'decent', November expected 'pretty decent'. But deal sizes compressed ₹40-50 Cr this quarter.
Private credit loan book trajectory — Pavan Kumar, Edelweiss Public Alternatives
AnsweredCash is healthy buffer at ₹1K Cr minimum. We will resume borrowing next quarter as yield improves. Management disciplined on risk-adjusted returns, will not chase growth if returns deteriorate.
Wealth AUM growth slowdown — Anubhav Goel, Cosma Ventures
PartialMarket-to-market effect. On steady-state growth basis, will add at 20%+ rates. Recruitment investment will drive growth in double digits over time, not immediately.
Capital deployment and buyback — Sanjay Pandit, 1729 Capital
AnsweredNBFC capital stuck; cannot easily exit. NSE stock just listed, locked up for six months. Will revisit buyback after March 2027 when NSE lockup expires. One year creep in capital plans.
Revenue growth reconciliation — Akshay Jawahar, Banyan Tree Associates
PartialNet gain on fair value changes (ARC side), broking revenue lower due to regulatory changes, write-backs ₹231 Cr last year vs ₹15 Cr this year. Half-on-half net revenue is actually ₹357 Cr (FY26) vs ₹582 Cr (FY27)—63% growth. Ignore quarterly volatility.
Wealth management new hire productivity — Kanishk Gupta, SS Family Office
AnsweredNew cohort: ₹75 Cr per RM. Existing cohort: ₹75-100 Cr per RM (mature). New cohort will be half that initially, but will double on ramp-up. Profitability recovery delayed to FY28.
Recurring vs transactional revenue split — Nilesh Doshi, Prospero Tree AMC
AnsweredYes. 50% from broking (12-15% of total recurring), institutional AUM growth, wealth recurring, and lending recurring. Rest 50% is transactional (M&A, deals, ARC recovery). Both businesses will grow, but transactional will remain volatile.
Guidance
Capital markets 15-20% growth over next 3-5 years
MediumIPO pipeline ₹183K Cr in Q2 suggests sustained momentum. But deal values compressed ₹40-50 Cr YoY; FY27 implies 12-15% growth, not 20%.
Private markets loan book 20% YoY growth
HighStandard loans grew 22% YoY to ₹4,748 Cr in Q2. Guidance reaffirmed; management disciplined on risk-adjusted returns.
Wealth management 20-25% AUM growth subject to market conditions
MediumRecurring AUM ₹37K Cr up 16% YoY; recruitment-driven productivity gains expected FY28. Current market volatility may cap near-term growth.
Overall revenue growth weighted ~20% YoY, 3-5 year horizon
MediumBlended across segments: capital markets (15-20%), private markets (20% loan book), wealth (20-25% AUM), affordable housing (25%+ AUM). FY27 actual +0.1% suggests guidance is 3-5Y forward-looking, not current FY.
Profitability to improve as recruitment phase matures
MediumWealth team expansion driving cost inflation; expected to normalize FY28. Operating leverage to drive margin expansion once recruitment cycle completes.
Risks the call surfaced
Capital markets cyclicality
High50% of revenue transactional (deals, M&A, capital markets). Q2 saw April-May weakness, Sept strength. Future quarters depend on market sentiment and IPO calendar.
Wealth management execution risk
MediumAggressive hiring (18 months of recruitment underway) is depressing near-term margins. Risk that new RMs do not reach mature RM productivity levels (₹75-100 Cr per RM target) in expected timeframe.
ARC and distressed credit volatility
MediumARC business subject to FVD changes and recovery timing lumpy. Q1 had ₹50+ Cr ARC recovery; Q2 quieter. Expected ₹250-300 Cr recovery by March uncertain.
Regulatory and broking headwinds
MediumWealth management includes broking revenue (12-15% of total recurring). Industry broking commissions lower in H1 vs H2 prior year. Regulatory environment may further compress margins.
Capital constraints and share liquidity
HighLarge capital deployed in NBFCs (illiquid); NSE stock just listed and locked up until March 2027. Limits capital deployment flexibility and shareholder returns. Stock trading below NAV but management cannot easily execute buyback.
Management
Score 7/10. Clear on segment metrics and strategy, transparent on headwinds (broking compression, deal size, recruitment costs). But deflected on buyback specifics and sometimes used 'market volatility' as catch-all excuse. Executing well on long-term initiatives (AUM growth, loan book expansion, Pre-IPO fund close) but missing near-term revenue targets (+0.1% YoY). Guidance of 15-20% growth not yet evidenced in quarterly delivery.
1 · Q3 FY27
Capital markets deal pipeline execution (₹130K Cr in filed transactions)
2 · March 2027
ARC ₹250-300 Cr recovery expected; NPA resolution ongoing
3 · Early FY28
Second performing credit fund first close; SIF platform launch
Near-term revenue stagnation conflicts with confident guidance, making the risk/reward neutral at current valuation.
Informational and educational content only. Not investment advice.